The ‘new normal’ at the EPO and more particularly plans to allow oral proceedings by videoconference even if parties don’t want it, have been leading to extensive debate over the last weeks. No less…
In my last post I deciphered several fake news, which spoil the public debate about compulsory licensing, I then mentioned a French bill proposal, introduced by Mr. Ronan Le Gleut in the Senate on…
The long and winding road, as The Beatles would put it, that led to the judgments of the CJEU in Teva et altri v. Gilead Sciences (Case C-121/17) and Royalty Pharma v. Deutsches Patent und Markenamt…
SEP-related case law in Europe is regularly reported in this blog, and other European platforms. Decisions of courts in UK, Germany, France and the Netherlands on FRAND royalties, anti-suit…
The greatest challenge for IP in the area of artificial intelligence (AI) will be to achieve some level of harmonisation worldwide. IP expert Adam Liberman has said this in the second part of a…
The European Patent Office has invited its users and stakeholders to take position on the first draft of its „Towards a new normal“ orientation document.
My experience with such public consultations…
At a time when a bill aiming at granting a compulsory license in the interest of public health in case of extreme sanitary emergency has just been filed in the French Senate on April 8, 2021[1], the…
Plaintiff’s arguments before the district court were often objectively unreasonable or frivolous; the frivolous nature of his appeal also warranted sanctions against plaintiff and his counsel of…
In the aftermath of the landmark decision ‘Unwired Planet vs Huawei’, a series of other FRAND litigations have followed suit. Cases such as Conversant vs ZTE/Huawei, Philips vs TCL, TQ Delta v ZyXel…
The Barcelona Court of Appeal (Section 15) overturned a first instance decision, making an interesting finding on the application of the "problem-solution approach": if the revocation claimant…
